HG-14-10-04
Product Specifications
UNSPSC Description
HG-14-10-04 is a potent ALK and mutant EGFR inhibitor with IC50s of 20 nM, 15.6 nM, 22.6 nM and 124.5 nM for ALK, EGFRLR/TM, EGFR19del/TM/CS and EGFRLR/TM/CS, respectively. HG-14-10-04 can be used to research anticancer[1][2].
Target Antigen
Anaplastic lymphoma kinase (ALK); EGFR
Type
Reference compound
Related Pathways
JAK/STAT Signaling;Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/HG-14-10-04.html
Solubility
DMSO : 20 mg/mL (ultrasonic)
Smiles
ClC1=CN=C(NC2=CC=C(N3CCC(N4CCN(C)CC4)CC3)C=C2OC)N=C1C5=CNC6=CC=CC=C65
Molecular Weight
532.08
References & Citations
[1]U.S. Pat. Appl. Publ. (2012), US 20120028924 A1|[2]Chen H, et al. Conformational Constrained 4-(1-Sulfonyl-3-indol)yl-2-phenylaminopyrimidine Derivatives as New Fourth-Generation Epidermal Growth Factor Receptor Inhibitors Targeting T790M/C797S Mutations. J Med Chem. 2022 May 12;65(9):6840-6858.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-15801/HG-14-10-04-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-15801/HG-14-10-04-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
1356962-34-9
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1076476-01 0.02 mg (E-Coli)
Recombinant Escherichia coli O157:H7 Peptidoglycan hydrolase flgJ (flgJ)
Ask
View Details 
MBS1076476-02 0.02 mg (Yeast)
Recombinant Escherichia coli O157:H7 Peptidoglycan hydrolase flgJ (flgJ)
Ask
View Details